molecular function |
| GO:0051015 | | actin filament binding | | Interacting selectively and non-covalently with an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits. |
| GO:0005509 | | calcium ion binding | | Interacting selectively and non-covalently with calcium ions (Ca2+). |
| GO:0005544 | | calcium-dependent phospholipid binding | | Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester, in the presence of calcium. |
| GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| GO:0005547 | | phosphatidylinositol-3,4,5-trisphosphate binding | | Interacting selectively and non-covalently with phosphatidylinositol-3,4,5-trisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3', 4' and 5' positions. |
| GO:0043325 | | phosphatidylinositol-3,4-bisphosphate binding | | Interacting selectively and non-covalently with phosphatidylinositol-3,4-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3' and 4' positions. |
| GO:0005546 | | phosphatidylinositol-4,5-bisphosphate binding | | Interacting selectively and non-covalently with phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions. |
biological process |
| GO:0007596 | | blood coagulation | | The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers. |
| GO:0016197 | | endosomal transport | | The directed movement of substances into, out of, or mediated by an endosome, a membrane-bounded organelle that carries materials newly ingested by endocytosis. It passes many of the materials to lysosomes for degradation. |
| GO:0007032 | | endosome organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of endosomes. |
| GO:0007599 | | hemostasis | | The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part. |
| GO:1900138 | | negative regulation of phospholipase A2 activity | | Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase A2 activity. |
| GO:1900004 | | negative regulation of serine-type endopeptidase activity | | Any process that stops, prevents or reduces the frequency, rate or extent of serine-type endopeptidase activity. |
cellular component |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0031902 | | late endosome membrane | | The lipid bilayer surrounding a late endosome. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |